Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
ADMA BIOLOGICS, INC. market cap for the quarter ending 2026-07-31 was $1.89B, a 58.93% decline year-over-year.
ADMA BIOLOGICS, INC. market cap for the quarter ending 2026-06-30 was $1.89B, a 56.61% decline year-over-year.
ADMA BIOLOGICS, INC. market cap for the quarter ending 2026-05-01 was $2.44B, a 56.62% decline year-over-year.
ADMA BIOLOGICS, INC. market cap for the quarter ending 2026-03-31 was $2.09B, a 55.87% decline year-over-year.
ADMA BIOLOGICS, INC. market cap for fiscal 2026 was $1.89B.
ADMA BIOLOGICS, INC. market cap for fiscal 2025 was $4.34B, a 6.98% increase from fiscal 2024.
ADMA BIOLOGICS, INC. market cap for fiscal 2024 was $4.06B, a 297.14% increase from fiscal 2023.
ADMA BIOLOGICS, INC. market cap for fiscal 2023 was $1.02B, a 18.72% increase from fiscal 2022.